CRISPR-Cas9 gene editing technology is being used to investigate the targets of 10 cancer drugs, seven of which are currently in clinical trials. In all cases, the scientists found that the proteins targeted by the drugs do not play important roles in cancer cell survival. Using CRISPR in this manner could potentially enable the identification of novel drug targets that could lead to more effective cancer therapies. Yourway is proud of our exceptional quality standards — we adhere to the strictest compliance to safeguard your materials from the point of origin to the patient, and have the technology required to handle cell and gene therapies.
Back to Index
6681 Snowdrift Road
Toll Free:
Fax:
Email:
